Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections

Luis E. Jauregui, Simon Babazadeh, Elyse Seltzer, Lisa Goldberg, Dainis Krievins, Mark Frederick, David Krause, Igors Satilovs, Zilvinas Endzinas, Jeffrey Breaux, William O'Riordan

Research output: Contribution to journalArticlepeer-review

263 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections'. Together they form a unique fingerprint.

Medicine & Life Sciences